Protagonist Therapeutics, Inc. Announces Upsizing and Pricing of Underwritten Public Offering of 7,000,000 Shares of Common Stock May 12, 2020 12:57AM
Protagonist Therapeutics (PTGX) Announces Proposed 5M Share Underwritten Public Offering of Common Stock May 11, 2020 07:00AM
Protagonist Therapeutics, Inc. Announces Proposed Underwritten Public Offering of Common Stock May 11, 2020 06:59AM
Protagonist Therapeutics (PTGX) PTG-300 Data is Misunderstood, Nomura Reiterates $29 PT Dec 4, 2019 06:07AM
Nomura/Instinet Reiterates Buy Rating on Protagonist Therapeutics (PTGX), Expects Upside in PTG-300 Results Nov 8, 2019 06:44AM


Jul 8, 2019 06:14AM Protagonist Therapeutics (PTGX) Reiterated Buy at Nomura Ahead of Ph2 Data
Dec 6, 2018 03:51AM Nomura/Instinet Starts Protagonist Therapeutics (PTGX) at Buy
Oct 12, 2017 05:45AM Protagonist Therapeutics (PTGX) Prices 3.53M Share Common Offering at $17/Sh
Oct 11, 2017 10:26PM Protagonist Therapeutics Prices Public Offering of Common Stock
Oct 11, 2017 04:03PM Protagonist Therapeutics (PTGX) Announces Proposed Common Share Offering
Oct 11, 2017 04:01PM Protagonist Therapeutics Announces Proposed Public Offering of Common Stock